Immediate clinical effectiveness of bepotastine besilate for patients with urticaria

Futoshi Kohda, Masutaka Furue, Shinichi Imafuku

Research output: Contribution to journalArticlepeer-review

3 Citations (Scopus)


A questionnaire survey concerning the immediate efficacy of bepotastine besilate (Talion®) was administered to 25 patients with urticaria. All 20 of the 20 patients (100%) who answered the question "When did you feel the effect of inhibition of itching?" reported noticing such an effect within 90 minutes after taking the medicine. Moreover, 92% expressed the opinion that they were conscious of the medication's effectiveness. As for duration of the effect, of 19 patients, 16% reported 4 hours, 32% reported 8 hours, and 47% reported 12 hours. Even though 33% of the patients reported drowsiness as a side effect, 84% wanted to continue using this medicine, proving its high efficacy.

Original languageEnglish
Pages (from-to)544-547
Number of pages4
JournalNishinihon Journal of Dermatology
Issue number5
Publication statusPublished - 2006

All Science Journal Classification (ASJC) codes

  • Dermatology


Dive into the research topics of 'Immediate clinical effectiveness of bepotastine besilate for patients with urticaria'. Together they form a unique fingerprint.

Cite this